NASDAQ: CRSP $14 Billion Large-Cap. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 1,186%. 1 Year Return 238%. 2021 YTD Return 15%. Since Earnings 101%.
The 52 Week Low is $32.30 set on Mon, Mar 16, 2020.
The 52 Week High is $215.10 set on Thu, Jan 14, 2021.
The All-Time High is $215.10 set on Thu, Jan 14, 2021.
Earnings Per Share
Price To Earnings Ratio
Dividend Yield
Dividend Rate
Ex-Dividend Date
Dividend Payment Date
Dividend Frequency
Dividend History
CRISPR Therapeutics AG trades on the NASDAQ. CRSP's market cap is 14.4 Billion.
CRISPR Therapeutics AG is a gene-editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 is a technology that allows for precise, directed changes to genomic DNA. The company advanced programs target beta-thalassemia and sickle cell disease, two hemoglobinopathies that have a high unmet medical need.
For Starters
Track your portfolio and more.
